, Nov. 9, 2010
/PRNewswire/ -- MicroAire Surgical Instruments LLC and Arthrex Inc. announced today that they have entered an agreement to settle a suit accusing Arthrex of patent infringement and breach of contract. At issue was the patented technology that MicroAire owns for minimally invasive treatment of Carpal Tunnel Syndrome.
Judge Norman K. Moon of the U.S. District Court for the Western District of Virginia approved the agreement on Thursday, October 28, without disclosing specific terms. The two companies issued this joint statement expressing their commitment to the safety and efficacy of endoscopic carpal tunnel release, also known as ECTR.
As a result of the agreement, MicroAire will now license its patented ECTR technology to Arthrex for an undisclosed fee; and both companies will maintain MicroAire's practice of requiring surgeon training for this procedure.
Alan Connor, MicroAire's Vice President of Operations, expressed his satisfaction with the settlement, noting the emphasis on patient safety and surgeon training. "MicroAire believes, as does Arthrex, that the endoscopic method of carpal tunnel release is a safe method that provides measurable patient benefits including a smaller scar, less pain and a faster recovery."
Anthony Cho, legal counsel for Arthrex, said, "Both Arthrex and MicroAire worked together in good faith to settle their differences amicably and should be commended for their efforts."
MicroAire's patented endoscopic treatment of carpal tunnel syndrome is a minimally invasive alternative to open-hand surgery. Endoscopy enables visualization of the surgical procedure on a video monitor through the use of a tiny camera inserted into a small incision in the crease of the patient's wrist. The treatment has been practiced for over twenty years and its safety and efficacy are supported by an impressive body of clinical data, including a randomized, prospective study involving more than 1,000 patients in 63 surgery centers. (Agee, JM et al. "Endoscopic Release of the Carpal Tunnel: A Randomized Prospective Multicenter Study." Journal of Hand Surgery. 1992; 17(6):987-995)
MicroAire Surgical Instruments LLC, located in Charlottesville, Virginia, is a leading designer, manufacturer and distributor of surgical products in three key areas: Orthopaedic Power Instruments, Endoscopic Soft-Tissue Release, and Aesthetic Plastic Surgery. MicroAire is a team, dedicated to enhancing quality of life by providing innovative surgical solutions that improve surgeon and patient outcomes. For more information, visit www.microaire.com.
Arthrex, headquartered in Naples, Florida, is a worldwide leader in sports medicine product development and educational services for orthopaedic surgeons. Over 5,000 products for arthroscopic and minimally invasive orthopaedic surgical procedures have been developed by Arthrex and are currently marketed worldwide. For more information, visit www.arthrex.com.
SOURCE MicroAire Surgical Instruments LLC